Clinical Trial Update: Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction [Phase 2]

View source ↗

Summary

Phase 2 trial updating on a combination regimen of clofarabine, idarubicin, and cytarabine for induction in acute myeloid leukemia; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)
• Idarubicin (idarubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-10-30